Status:

TERMINATED

Safety and Efficacy of Pulsed-field Ablation for Atrial Fibrillation in High Versus Low-volume Ablation Centers (SAFFICIENT)

Lead Sponsor:

Texas Cardiac Arrhythmia Research Foundation

Conditions:

Atrial Fibrillation

Eligibility:

All Genders

18-85 years

Brief Summary

Catheter ablation using radiofrequency (RF) energy has been widely adopted for management of atrial fibrillation (AF) for the past several years. However, heterogeneity of outcomes and complication r...

Detailed Description

Prospective, non-randomized, multi-center study NUMBER OF STUDY CENTERS: Up to 80 TRIAL OBJECTIVE To evaluate safety of the VARIPULSE™ Catheter when used in conjunction with the TRUPULSE™ Generator fo...

Eligibility Criteria

Inclusion

  • Age: \>≥18 years
  • Symptomatic Paroxysmal or Persistent AF patients of ≤ 1 year
  • First ablation or redo procedure to treat AF
  • Willing to provide written informed consent
  • Able and willing to comply with all testing and requirements

Exclusion

  • Long-standing persistent AF Page 17 of 70
  • Any condition contraindicating chronic anticoagulation
  • Prosthetic mechanical valves
  • Recent MI (in \<3 months)
  • Active systemic infection
  • Pregnant or lactating women
  • Current enrollment in an investigational study evaluating another device or drug.
  • Documented left atrial (LA) thrombus by imaging within 48 hours before procedure (computed tomography (CT), transesophageal echocardiogram (TEE), or intracardiac echocardiogram (ICE) at the beginning of the procedure).
  • Uncontrolled heart failure or New York Heart Association (NYHA) Class IV
  • Significant congenital anomaly or medical problem that in the opinion of the investigator would preclude enrollment in this study
  • Life expectancy less than 12 months

Key Trial Info

Start Date :

August 29 2024

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 4 2025

Estimated Enrollment :

75 Patients enrolled

Trial Details

Trial ID

NCT06488820

Start Date

August 29 2024

End Date

April 4 2025

Last Update

May 28 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Texas Cardiac Arrhythmia

Austin, Texas, United States, 78705